Predictors of AMD Treatment Response

A letter to the editor that refers to the following article :  Frank G. Holz, Winfried Amoaku, Juan Donate, Robyn H. Guymer, Ulrich Kellner, Reinier O. Schlingemann, Andreas Weichselberger, Giovanni Staurenghi, SUSTAIN Study Group. Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study Ophthalmology, Volume 118, Issue 4, April 2011, Pages 663-671